Skip Navigation LinksHome > March 2014 - Volume 9 - Issue 3 > Contributor Index

March 2014 - Volume 9 - Issue 3 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Author Name Article
Fang, Douglas D. PhD

HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Feld, Ron MD

A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy: The “SMART” Approach for Resectable Malignant Pleural Mesothelioma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Felip, Enriqueta MD

Phase I Safety and Pharmacokinetic Study of the PI3K/mTOR Inhibitor SAR245409 (XL765) in Combination with Erlotinib in Patients with Advanced Solid Tumors

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fisher, Richard John MBBS, PhD

Absence of a Relationship between Tumor 18F-fluorodeoxyglucose Standardized Uptake Value and Survival in Patients Treated with Definitive Radiotherapy for Non–Small-Cell Lung...

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Forde, Patrick M. MD

Systemic Therapy, Clinical Outcomes, and Overall Survival in Locally Advanced or Metastatic Pulmonary Carcinoid: A Brief Report

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Friedel, Godehard MD

Detection of Rearrangements and Transcriptional Up-Regulation of ALK in FFPE Lung Cancer Specimens Using a Novel, Sensitive, Quantitative Reverse Transcription Polymerase Chain...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Friedman, David B. PhD

Discovery of New Membrane-Associated Proteins Overexpressed in Small-Cell Lung Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fritz, Peter MD

Detection of Rearrangements and Transcriptional Up-Regulation of ALK in FFPE Lung Cancer Specimens Using a Novel, Sensitive, Quantitative Reverse Transcription Polymerase Chain...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View